MG217 PSORIASIS THERAPEUTIC CONDITIONER- salicylic acid shampoo Wisconsin Pharmacal Company Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. ---------- Active Ingredient Salicylic Acid 3% Purpose Psoriasis, Seborrheic Dermatitis, Dandruff Treatment Uses For the temporary relief of these symptoms associate with psoriasis, seborrheic dermatitis or dandruff itching scaling flaking, reness irritaion of the scalp Helps prevent recurrence. Warnings For external use only. Ask a doctor before use if condition covers larger area of body, consult your doctor before using this product. When using this product avoid contact wtih the eyes. If contact occurs, rinse thoroughly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed, consult a doctor. Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center Immediately. Directions wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly. for best results, use at least twice a week or as directed by a physician. Inactive Ingredients Purified water, Sodium laureth sulfate, Cocamidopropyl betaine, Lauryl glucoside, Sodium citrate, Coco-glucoside, Glyceryl oleate, Propanediol, Glycerin, Polyquaterinum-44, Sodium benzoate, Panthenol, Calendula officinalis flower extract, Chamomilla recutita (matricaria) flower extract, Propylene glycol, Citric acid, Chlorhexidine gluconate, Disodium EDTA MG217 PSORIASIS THERAPEUTIC CONDITIONER salicylic acid shampoo Product Information Product T ype HUMAN OTC DRUG Ite m Code (Source ) NDC:6 8 0 9 3-7242 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 0 .0 3 g in 1 g Inactive Ingredients Ingredient Name Strength SO DIUM BENZO ATE (UNII: OJ245FE5EU) CITRIC ACID MO NO HYDRATE (UNII: 29 6 8 PHW8 QP) CHLO RHEXIDINE GLUCO NATE (UNII: MOR8 4MUD8 E) WATER (UNII: 0 59 QF0 KO0 R) SO DIUM LAURETH SULFATE (UNII: BPV39 0 UAP0 ) CO CAMIDO PRO PYL BETAINE (UNII: 5OCF3O11KX) SO DIUM CITRATE (UNII: 1Q73Q2JULR) GLYCERIN (UNII: PDC6 A3C0 OX) PANTHENO L (UNII: WV9 CM0 O6 7Z) CALENDULA O FFICINALIS FLO WER (UNII: P0 M7O4Y7YD) MATRICARIA CHAMO MILLA FLO WERING TO P O IL (UNII: SA8 AR2W4ER) PRO PYLENE GLYCO L (UNII: 6 DC9 Q16 7V3) EDETATE DISO DIUM (UNII: 7FLD9 1C8 6 K) LAURYL GLUCO SIDE (UNII: 76 LN7P7UCU) CO CO GLUCO SIDE (UNII: ICS79 0 225B) GLYCERYL O LEATE (UNII: 4PC0 54V79 P) PRO PANEDIO L (UNII: 59 6 5N8 W8 5T) PO LYQ UATERNIUM-4 4 (2 0 0 0 0 0 MW) (UNII: TTD9 VOM8 3O) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:6 8 0 9 3-7242-1 1 in 1 CARTON 11/0 1/20 15 1 28 3 g in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct Marketing Information Marke ting Cate gory Application Numbe r or Monograph Citation Marke ting Start Date Marke ting End Date OTC mo no graph final part333D 11/0 1/20 15 Labeler - Wisconsin Pharmacal Company (800873986) Establishment Name Addre ss ID/FEI Busine ss Ope rations Wisco nsin Pharmacal Co mpany 8 0 0 8 739 8 6 manufacture(6 8 0 9 3-7242) Revised: 3/2016 Wisconsin Pharmacal Company.